3 completed, 2 terminated, 1 unknown. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Terminated 2, Unknown 1 |
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow Interferon-beta: new trials by email Literature Review of Interferon-beta trials Research Report on Interferon-beta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3), Interferon-beta - Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive | Phase 1 | Unknown | Fundació Institut Germans Trias i Pujol | 16 | 2017-07-06 | 2023-07-07 |
| Mesenchymal Stem Cells (MSC) for Ovarian Cancer MSC-INFβ, Questionnaires - Ovarian Cancer | Phase 1 | Completed | M.D. Anderson Cancer Center | 5 | 2016-05-16 | 2019-07-18 |
| Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma Avelumab, Laboratory Biomarker Analysis, MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells - Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 8 | 2015-11-06 | 2022-03-22 |
| Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma Aldesleukin, Laboratory Biomarker Analysis, MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells - Recurrent Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 4 | 2013-02-01 | 2017-04-19 |
| Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II Interferon Beta - Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Faron Pharmaceuticals Ltd | 37 | 2009-02-01 | 2015-05-27 |
| Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas Interferon-beta - Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 | Completed | Biogen | 12 | 2002-04-02 | 2020-11-17 |
Carcinoma, Merkel Cell (2) · Acute Lung Injury (1) · Adenoviridae Infections (1) · Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Ovarian Neoplasms (1) · Respiratory Distress Syndrome (1)
Fred Hutchinson Cancer Center (2) · Biogen (1) · Faron Pharmaceuticals Ltd (1) · Fundació Institut Germans Trias i Pujol (1) · M.D. Anderson Cancer Center (1)
United States (4) · Spain (1) · United Kingdom (1)
Aude Chapuis (2) · Alan Davidson, MD (1) · Alexander Binning, MD (1) · Amanda L. Olson, MD (1) · Cristina Ramo, MD.PhD.Neurologist (1) · Geoff Bellingan, MD (1) · Martin Kuper, MD (1) · Martin Stotz, MD (1) · Mathew Wise, MD (1) · Richard Beale, MD (1) · Timothy Walsh, MD (1)
P30CA015704 (2), 2015 (1), K24CA139052 (1), R01CA176841 (1)